Dear Secretary Dooley:
Re: Request for temporary exemption for use of thimerosal-containing vaccine
Due to delays in the delivery of preservative-free flu vaccine across the U.S., we request a temporary
exemption be granted to allow health care providers in California to administer thimerosal-containing
vaccine to children under three years of age and pregnant women.
The United States is experiencing a national shortage of Fluzone pediatric pre-filled syringes,
manufactured by Sanofi Pasteur. This is the only preservative-free injectable vaccine that can be
administered to children ages 6-35 months under California law (California Health and Safety Code
Section 124172 ). Additionally the delivery of FluMist, the live attenuated influenza vaccine (LAIV) that is
administered intranasally, is also delayed throughout the country. FluMist has no preservative and can
be administered to a two-year old child if there are no contraindications. The manufacturer reports that
the vaccine is delayed due to production and shipping issues.